HomeCollaboration with Google Cloud to accelerate small-molecule discovery using AI agents

Collaboration with Google Cloud to accelerate small-molecule discovery using AI agents

A new collaboration is expected to accelerate, scale and advance small-molecule discovery and optimisation for pharmaceutical and agricultural products.

Evogene, a computational chemistry company focused on AI-driven small-molecule design for the pharmaceutical and agricultural industries, has announced an expanded phase of its collaboration with Google Cloud.

Under this new phase, the collaboration will focus on developing and integrating advanced AI Agents into Evogene’s ChemPass AI™ platform, its proprietary engine for small-molecule discovery and optimisation, using Google Cloud’s Vertex AI platform.

The goal is to increase the speed, precision, and efficiency of identifying and optimising small molecules for drug and ag-chemical development.

This announcement marks the second major milestone in the partnership between Evogene and Google Cloud, following the successful collaboration announced in October 2024.

The initial phase focused on building a generative AI foundation model that now serves as a core component of ChemPass AI™.

This powerful capability drove Evogene’s recent collaborations, and the addition of our new agent technology positions the company to broaden its offering and accelerate future partnerships.

AI agents represent a new generation of artificial intelligence systems that can independently plan, reason, and execute complex, multi-step scientific workflows.

When integrated into ChemPass AI™, these agents are designed to automate and scale key discovery processes, enable large-scale parallel molecular exploration, shorten design–make–test–analyse cycles, and improve the accuracy and success rate of designing small-molecule based products.

These capabilities directly support Evogene’s core objective: identifying high-quality small molecules that meet multiple, stringent criteria required to become commercially viable product candidates.

The expanded collaboration is expected to further strengthen Evogene’s position as a leader in next-generation molecular design for both pharmaceutical and agricultural markets.

- Advertisment -
- Advertisment -
- Advertisment -
- Advertisment -
- Advertisment -

Most Popular

Popular categories